Annals of Coloproctology

Volume 34(5); October 2018

Editorial

Waiting and Hope: Optimal Time Interval for Surgery After Long-Course Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer: Chang Hyun Kim; Ann Coloproctol. 2018;34(5):227-228. Published online October 31, 2018; DOI: https://doi.org/10.3393/ac.2018.08.16

3,424 View
103 Download

PDF

Review

Lateral Lymph Node Dissection With the Focus on Indications, Functional Outcomes, and Minimally Invasive Surgery: Min Jung Kim, Jae Hwan Oh; Ann Coloproctol. 2018;34(5):229-233. Published online October 31, 2018; DOI: https://doi.org/10.3393/ac.2018.10.26

5,434 View
180 Download
14 Web of Science
13 Citations

Abstract PDF

The lateral lymph node dissection (LLND) is still a subject of great debate as to the appropriate treatment for patients with mid to low advanced rectal cancer. The guidelines of the Japanese Society for Cancer of the Colon and Rectum recommend a LLND for patients with T3/4 rectal cancer below the peritoneal reflection. However, in most Western countries, a routine LLND is not recommended unless a node or nodes are clinically suspicious for metastasis. Even after preoperative chemoradiotherapy (CRT), an 8% to 12% lateral pelvic recurrence was noted. The size of the lateral lymph node and responsiveness to preoperative CRT should be the main factors for selecting appropriate patients to undergo a LLND. In addition, from the recent literature, a laparoscopic LLND is safe and oncologically feasible and might have some advantages in short-term outcomes.

Citations

Citations to this article as recorded by

Totally Extraperitoneal Approach for Recurrent Lateral Pelvic Lymph Nodes After Rectal Cancer Surgery
Tae-Gyun Lee, Hongmin Ahn, Hye-Rim Shin, Mi Jeong Choi, Min Hyeong Jo, Heung-Kwon Oh, Duck-Woo Kim, Sung-Bum Kang
Diseases of the Colon & Rectum.2024;[Epub] CrossRef
Laparoscopic Extraperitoneal Approach for Lateral Pelvic Node Dissection in Rectal Cancer: Techniques and Short-Term Outcomes
Ji-Seon Kim, Jin Kim, Se-Jin Baek, Hyunmi Park, Jung-Myun Kwak, Seon-Hahn Kim
Surgical Innovation.2023; 30(1): 13. CrossRef
Lateral pelvic sentinel lymph node biopsy using indocyanine green fluorescence navigation: can it be a powerful supplement tool for predicting the status of lateral pelvic lymph nodes in advanced lower rectal cancer
Hao Su, Zheng Xu, Mandula Bao, Shou Luo, Jianwei Liang, Wei Pei, Xu Guan, Zheng Liu, Zheng Jiang, Mingguang Zhang, Zhixun Zhao, Weisen Jin, Haitao Zhou
Surgical Endoscopy.2023; 37(5): 4088. CrossRef
Anatomical Validation of Internal Iliac Vessels Assessed by Three-dimensional Angiographic Analysis
Yuya Takenaka, Naohito Beppu, Masaki Otani, Kazuma Ito, Ayako Imada, Takaaki Matsubara, Jihyung Song, Kei Kimura, Kozo Kataoka, Motoi Uchino, Hiroki Ikeuchi, Masataka Ikeda
Journal of the Anus, Rectum and Colon.2023; 7(3): 186. CrossRef
Indocyanine green dye and its application in gastrointestinal surgery: The future is bright green
Zavier Yongxuan Lim, Swetha Mohan, Sunder Balasubramaniam, Saleem Ahmed, Caroline Ching Hsia Siew, Vishal G Shelat
World Journal of Gastrointestinal Surgery.2023; 15(9): 1841. CrossRef
Lateral Lymph Nodes in Rectal Cancer: Do we all Think the Same? A Review of Multidisciplinary Obstacles and Treatment Recommendations
Tania C. Sluckin, Alice M. Couwenberg, Doenja M.J. Lambregts, Sanne-Marije J.A. Hazen, Karin Horsthuis, Philip Meijnen, Regina G.H. Beets-Tan, Pieter J. Tanis, Corrie A.M. Marijnen, Miranda Kusters
Clinical Colorectal Cancer.2022; 21(2): 80. CrossRef
Establishment and validation of a nomogram for predicting potential lateral pelvic lymph node metastasis in low rectal cancer
Atsuhiko Sumii, Koya Hida, Yoshiharu Sakai, Nobuaki Hoshino, Daisuke Nishizaki, Tomonori Akagi, Meiki Fukuda, Tomohiro Yamaguchi, Ichiro Takemasa, Takuya Tokunaga, Jun Watanabe, Masahiko Watanabe
International Journal of Clinical Oncology.2022; 27(7): 1173. CrossRef
Significant improvement after training in the assessment of lateral compartments and short-axis measurements of lateral lymph nodes in rectal cancer
Tania C. Sluckin, Sanne-Marije J. A. Hazen, Karin Horsthuis, Doenja M. J. Lambregts, Regina G. H. Beets-Tan, Pieter J. Tanis, Miranda Kusters
European Radiology.2022; 33(1): 483. CrossRef
Short-term outcomes of laparoscopic lateral pelvic node dissection for advanced lower rectal cancer
Katsuji Tokuhara, Hidehiko Hishikawa, Terufumi Yoshida, Yosuke Ueyama, Kazuhiko Yoshioka, Mitsugu Sekimoto
Surgical Endoscopy.2021; 35(4): 1572. CrossRef
Effect of lateral lymph node dissection on the quality of life and genitourinary function after neoadjuvant chemoradiotherapy for rectal cancer
Ryun Kyong Ha, Boram Park, Sung Chan Park, Hee Jin Chang, Jae Hwan Oh
Annals of Surgical Treatment and Research.2021; 100(2): 109. CrossRef
Does adding lateral pelvic lymph node dissection to neoadjuvant chemotherapy improve outcomes in low rectal cancer?
Brendan Zhen Yang Law, Zeneera Yusuf, Yu En Ng, Emad H. Aly
International Journal of Colorectal Disease.2020; 35(8): 1387. CrossRef
Lateral pelvic lymph node dissection in the management of locally advanced low rectal cancer: Summary of the current evidence
Mootaz Elhusseini, Emad H. Aly
Surgical Oncology.2020; 35: 418. CrossRef
Does lateral lymph node dissection for low rectal cancer improve overall survival? Protocol for a systematic review and meta-analysis
Jeremy Meyer, Niki Christou, Christophe Combescure, Nicolas Buchs, Frédéric Ris
International Journal of Surgery Protocols.2019; 17: 1. CrossRef

Original Articles

The Impact of the Outcome of Treating a High Anal Fistula by Using a Cutting Seton and Staged Fistulotomy on Saudi Arabian Patients: Bader Hamza Shirah, Hamza Asaad Shirah; Ann Coloproctol. 2018;34(5):234-240. Published online October 10, 2018; DOI: https://doi.org/10.3393/ac.2018.03.23

9,861 View
168 Download
14 Web of Science
13 Citations

Abstract PDF

Purpose
A cutting seton is used after a partial distal fistulotomy to treat patients with a high exrasphincteric fistula in ano to avoid fecal incontinence and recurrence. In Saudi Arabia, religious practices necessitate complete cleanness, which makes conditions affecting anal continence a major concern to patients affected by an anal fistula. Therefore, we aimed to evaluate the efficiency of the cutting seton in treating a high anal fistula among Saudi Arabians.
Methods
Between January 2005 and December 2014, a prospective study was done for 372 Saudi Arabian patients diagnosed as having a high anal fistula and treated with a cutting seton at Al-Ansar General Hospital, Medina, Saudi Arabia. 0-silk sutures were used. All patients underwent the same preoperative assessment, operative technique, and postoperative follow-up. Weekly, the seton was tightened in outpatient clinics.
Results
Two hundred ninety-eight patients (80.1%) were males and 74 (19.9%) females. The duration of symptoms varied from 3–21 months. The fistula healed completely in 363 patients (97.6%); 58 patients (15.6%) reported some degree of incontinence to flatus, but none to feces. In 9 patients (2.4%) the fistula recurred.
Conclusion
The utilization of the cutting seton method in the treatment of patients with a high anal fistula is highly efficient as it simultaneously drains the abscess, cuts the fistulous tract, and causes fibrosis along the tract. Treatment of a high anal fistula by using a staged fistulotomy with a cutting seton was very rewarding to Saudi Arabian patients who feared anal incontinence for religious reasons and was associated with low postoperative complication and recurrence rates.

Citations

Citations to this article as recorded by

Cutting seton for the treatment of cryptoglandular fistula-in-ano: a systematic review and meta-analysis
J. Khamar, A. Sachdeva, T. McKechnie, Y. Lee, L. Tessier, D. Hong, C. Eskicioglu
Techniques in Coloproctology.2024;[Epub] CrossRef
Evaluation surgical strategies in perianal fistulas treatment: Efficacy draining seton compared to other surgical approaches; a case‐control study
Amir Ghasemlouei, Amirhosein Naseri, Ali Ashjaei, Shahryar Sadeghi, Amir Keshvari
Health Science Reports.2024;[Epub] CrossRef
Assessing the suitability of video-assisted anal fistula treatment for obese patients compared to conventional surgery: a question worth investigating
Xiao-Li Tang, Zi-Yang Xu, Jun Yang, Zhe Yang, Zhi-Gang Wang, Zheng-Yun Zhang, Jing Yao
International Journal of Colorectal Disease.2024;[Epub] CrossRef
Fistulectomy and primary sphincteroplasty in complex anal fistula treatment: a hospital-based long-term follow-up study
Fakhrosadat Anaraki, Mohammad Reza Nikshoar, Arsh Haj Mohamad Ebrahim Ketabforoush, Rojin Chegini, Nasrin Borumandnia, Mehdi Tavallaei
Techniques in Coloproctology.2023; 27(2): 145. CrossRef
Exploring Health-Related Quality of Life in Patients with Anal Fistulas: A Comprehensive Study
Tudor Mateescu, Lazar Fulger, Durganjali Tummala, Aditya Nelluri, Manaswini Kakarla, Lavinia Stelea, Catalin Dumitru, George Noditi, Amadeus Dobrescu, Cristian Paleru, Ana-Olivia Toma
Life.2023; 13(10): 2008. CrossRef
Surgical treatment of anal fistula
A. Ya. Ilkanich, V. V. Darwin, E. A. Krasnov, F. Sh. Aliyev, K. Z. Zubailov
Сибирский научный медицинский журнал.2023; 43(5): 74. CrossRef
Evaluation of the Cutting Seton Technique in Treating High Anal Fistula
Asim M Almughamsi, Mohamed Khaled S Zaky, Abdullatif M Alshanqiti, Ibrahim S Alsaedi, Hamed I Hamed, Tariq E Alharbi, Ali A Elian
Cureus.2023;[Epub] CrossRef
Comparison of loose combined cutting seton and traditional cutting seton for high anal fistula: a meta-analysis
Yi SUN, Chunqiang WANG, Tianye HUANG, Xuebing WANG
Gazzetta Medica Italiana Archivio per le Scienze Mediche.2023;[Epub] CrossRef
Evaluating the Efficacy of Cutting Setons for the Treatment of Anal Fistulas
Miguel E. Gomez, Koianka Trencheva, Matthew Symer, Kelly Garrett, Jeffrey W. Milsom, Parul J. Shukla
Indian Journal of Surgery.2022; 84(5): 961. CrossRef
Advancing standard techniques for treatment of perianal fistula; when tissue engineering meets seton
Hojjatollah Nazari, Zahra Ebrahim Soltani, Reza Akbari Asbagh, Amirsina Sharifi, Abolfazl Badripour, Asieh Heirani Tabasi, Majid Ebrahimi Warkiani, Mohammad Reza Keramati, Behnam Behboodi, Mohammad Sadegh Fazeli, Amir Keshvari, Mojgan Rahimi, Seyed Mohsen
Health Sciences Review.2022; 3: 100026. CrossRef
Treatment of the fistula tract with laser ablation in high anal fistula
Erkan Karacan, Eyüp Murat Yılmaz
Journal of Clinical Medicine of Kazakhstan.2022; 19(6): 43. CrossRef
Influence of the cotton and silastic seton on the distance of the anal sphincter cables after fistulotomy in rats
Ana Laura Sanches Lima, Beatriz Schorro Gianini, Bruna Miranda Santana, Carlos Henrique Marques dos Santos, Doroty Mesquita Dourado, Juliano Seger Falcão, Lucas Bannwart, Sara Jéssica Falcão Câmara
Journal of Coloproctology.2020; 40(01): 056. CrossRef
A Commentary on the article: “Risk factors for recurrence after anal fistula surgery: A meta-analysis”, Int J Surg 2019;69:153–164
F. Karimian
International Journal of Surgery.2019; 71: 79. CrossRef

Optimal Time Interval for Surgery After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer: Analysis of Health Insurance Review and Assessment Service Data: Min Jung Kim, Jin Suk Cho, Eun Mi Kim, Woo Ah Ko, Jae Hwan Oh; Ann Coloproctol. 2018;34(5):241-247. Published online October 31, 2018; DOI: https://doi.org/10.3393/ac.2018.01.01

5,187 View
116 Download
18 Web of Science
19 Citations

Abstract PDF

Purpose
Pathologic downstaging of rectal cancer has been suggested to be associated with the time interval from chemoradiotherapy (CRT) completion to surgery. We aimed to evaluate the effect of this time interval for patients with rectal cancer on the pathologic response.
Methods
All patients with rectal cancer undergoing neoadjuvant CRT with evaluable data were selected from among the Health Insurance Review and Assessment Service data. Patients were divided into groups according to the time between CRT and surgery. CRT responses were analyzed.
Results
Two hundred forty-nine patients were included, of whom 86 (34.5%) were in the 5- to 7-week interval, 113 (45.4%) in the 7- to 9-week interval, 38 (15.3%) in the 9- to 11-week interval, and 12 (4.8%) in the >11-week interval. The median time interval between CRT completion and surgery was 7.4 weeks (range: 5–22.7 weeks; interquartile range, 6.7–8.7 weeks). Surgery 9–11 weeks after CRT completion resulted in the highest, but not statistically significant, pathologic complete response (pCR) rate (3 patients, 8.6%; P = 0.886), no pCR was noted in the >11-week interval group. Results for downstaging in the 9- to 11-week interval group were as follows: T downstaging, 38.2% (P = 0.735); N downstaging, 50.0% (P = 0.439); and TN downstaging, 52.9% (P = 0.087). The 3-year overall survival rates for the 5- to 7-week, 7- to 9-week, 9- to 11-week, and >11-week interval groups were 93.0%, 85.0%, 81.6%, and 91.7%, respectively (P = 0.326).
Conclusion
Delaying surgery by 9 to 11 weeks may increase TN downstaging, but delaying for over 11 weeks may not increase additional tumor downstaging from long-course CRT.

Citations

Citations to this article as recorded by

Time interval between neoadjuvant radiation therapy and surgery and overall survival of rectal cancer patients
Saber A Amin, Megha Patel, Chi Lin
Colorectal Cancer.2024;[Epub] CrossRef
Prediction of pathological complete response and prognosis in locally advanced rectal cancer
Yi-Jun Xu, Dan Tao, Song-Bing Qin, Xiao-Yan Xu, Kai-Wen Yang, Zhong-Xu Xing, Ju-Ying Zhou, Yang Jiao, Li-Li Wang
World Journal of Gastrointestinal Oncology.2024; 16(6): 2520. CrossRef
Determining the optimal radiation‐surgery interval (RSI) for oncologic proctectomy following radiotherapy for rectal adenocarcinoma
Matthew C. Bobel, Michael F. McGee
Journal of Surgical Oncology.2023; 127(8): 1252. CrossRef
A Predictive Model to Evaluate Pathologic Complete Response in Rectal Adenocarcinoma
Shuiwang Qing, Lei Gu, Tingting Du, Xiaolan Yin, Ke-jia Zhang, Huo-jun Zhang
Technology in Cancer Research & Treatment.2023;[Epub] CrossRef
Initial magnetic resonance imaging tumour regression grade (mrTRG) as response evaluation after neoadjuvant treatment predicts sustained complete response in patients with rectal cancer
Chikako Suzuki, Sandra Kapoun Halperin, Per J. Nilsson, Anna Martling, Torbjörn Holm
European Journal of Surgical Oncology.2022; 48(7): 1643. CrossRef
Does a long interval between neoadjuvant chemoradiotherapy and surgery benefit the clinical outcomes of locally advanced rectal cancer? A systematic review and meta analyses
Miao Yu, Deng-Chao Wang, Sheng Li, Li-Yan Huang, Jian Wei
International Journal of Colorectal Disease.2022; 37(4): 855. CrossRef
Machine Learning for Sensing Applications: A Tutorial
Vahideh Shirmohammadli, Behraad Bahreyni
IEEE Sensors Journal.2022; 22(11): 10183. CrossRef
Lymph Nodes With Germinal Centers Are Not Associated With Tumor Response After Neoadjuvant Treatment in Locally Advanced Rectal Cancer
Ihsane El Otmani, Boubacar Effared, Fatima El Agy, Mohammed El Abkari, Khalid Mazaz, El Bachir Benjelloun, Abdelmalek Ousadden, Zineb Benbrahim, Touria Bouhafa, Laila Chbani
Clinical Pathology.2022; 15: 2632010X2211329. CrossRef
Predictors of pathological complete response following neoadjuvant chemoradiotherapy for rectal cancer
Asif Mehraj, ArshadA Baba, Bushra Khan, MudassirAhmad Khan, RaufA Wani, FazlQ Parray, NisarA Chowdri
Journal of Cancer Research and Therapeutics.2022; 18(9): 391. CrossRef
Timing to achieve the highest rate of pCR after preoperative radiochemotherapy in rectal cancer: a pooled analysis of 3085 patients from 7 randomized trials
Maria Antonietta Gambacorta, Carlotta Masciocchi, Giuditta Chiloiro, Elisa Meldolesi, Gabriella Macchia, Johan van Soest, Fenke Peters, Laurence Collette, Jean-Pierre Gérard, Samuel Ngan, C. Claus Rödel, Andrea Damiani, Andre Dekker, Vincenzo Valentini
Radiotherapy and Oncology.2021; 154: 154. CrossRef
Improvement in the Assessment of Response to Preoperative Chemoradiotherapy for Rectal Cancer Using Magnetic Resonance Imaging and a Multigene Biomarker
Eunhae Cho, Sung Woo Jung, In Ja Park, Jong Keon Jang, Seong Ho Park, Seung-Mo Hong, Jong Lyul Lee, Chan Wook Kim, Yong Sik Yoon, Seok-Byung Lim, Chang Sik Yu, Jin Cheon Kim
Cancers.2021; 13(14): 3480. CrossRef
Temporal determinants of tumour response to neoadjuvant rectal radiotherapy
Kendrick Koo, Rachel Ward, Ryan L. Smith, Jeremy Ruben, Peter W. G. Carne, Hany Elsaleh, Mona Pathak
PLOS ONE.2021; 16(6): e0254018. CrossRef
Factors Predicting Pathological Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer: The Experience of a Single Institution with 269 Patients (STONE-01)
Michele Fiore, Pasquale Trecca, Luca E. Trodella, Roberto Coppola, Marco Caricato, Damiano Caputo, Alessandro Coppola, Gian M. Petrianni, Gabriele D’Ercole, Edy Ippolito, Rolando M. D’Angelillo, Sara Ramella
Cancers.2021; 13(23): 6074. CrossRef
Chemoradiotherapy alone or chemoradiotherapy followed by surgery in rectal cancer
Fabian Lunger, Georgios Peros
memo - Magazine of European Medical Oncology.2020; 13(3): 324. CrossRef
Preoperative Short-course Radiotherapy for Lower Rectal Cancer
Hidenori Yanagi, Naohito Beppu, Ryo Okamoto, Yoshihiko Nakamoto, Takayoshi Nakajima, Noriko Ichise, Tsukasa Aihara, Norihiko Kamikonya
Nippon Daicho Komonbyo Gakkai Zasshi.2020; 73(10): 424. CrossRef
Meta-analysis of the effect of extending the interval after long-course chemoradiotherapy before surgery in locally advanced rectal cancer
É J Ryan, D P O'Sullivan, M E Kelly, A Z Syed, P C Neary, P R O'Connell, D O Kavanagh, D C Winter, J M O'Riordan
British Journal of Surgery.2019; 106(10): 1298. CrossRef
Impact of PET/CT for Restaging Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation
Eric Sorenson, Fernando Lambreton, Jian Q. Yu, Tianyu Li, Crystal S. Denlinger, Joshua E. Meyer, Elin R. Sigurdson, Jeffrey M. Farma
Journal of Surgical Research.2019; 243: 242. CrossRef
Neoadjuvant radiotherapy for rectal cancer management
Gerard Feeney, Rishabh Sehgal, Margaret Sheehan, Aisling Hogan, Mark Regan, Myles Joyce, Michael Kerin
World Journal of Gastroenterology.2019; 25(33): 4850. CrossRef
Waiting and Hope: Optimal Time Interval for Surgery After Long-Course Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer
Chang Hyun Kim
Annals of Coloproctology.2018; 34(5): 227. CrossRef

Discrepancy of Medical Terminology Regarding Colorectal Surgery Between South and North Korea: Dayoung Ko, Heung-Kwon Oh, Jangwhan Jo, Hyun Hui Yang, Min-Hyun Kim, Myung Jo Kim, Sung Il Kang, Duck-Woo Kim, Sung-Bum Kang; Ann Coloproctol. 2018;34(5):248-252. Published online October 31, 2018; DOI: https://doi.org/10.3393/ac.2017.10.01

3,644 View
103 Download
2 Web of Science
2 Citations

Abstract PDF

Purpose
We aimed to investigate the extent of heterogeneity in medical terminology between South and North Korea by comparing medical terms related to the colorectal system.
Methods
North Korean medical terms were collected from the sections on diseases of the small intestine and colon in a surgery textbook from North Korea, and those terms were compared with their corresponding terms in a South Korean medical terminology textbook. The terms were categorized as either identical, similar, showing disparity, or not used in South Korea. In a subsection analysis, the terms were allocated to pathophysiology, diagnosis, symptoms and examination, drugs, testing, treatment, or others according to the categorization used in the textbook.
Results
We found 705 terms in the North Korean textbook, most of which were pathophysiological terms (206, 29.2%), followed by diagnostic terms (165, 23.4%) and symptom and examination terms (122, 17.3%). Treatment-, drug-, and testing-related terms constituted 15.5%, 5.8%, and 4.1% of the 705 terms, respectively. There were 331 identical terms (47.0%) and 146 similar terms (20.7%); 126 terms (17.9%) showed disparity. Another 102 terms (14.5%) were not used in South Korea. The pathophysiological terms were the least heterogeneous, with 61.2% being identical terms used in both countries. However, 26.8% of the terms in the drug category were not used in South Korea.
Conclusion
The present study showed that less than 50% of the terms for the colorectal system used in South and North Korea were identical. As the division between South and North Korea persists, the heterogeneity of medical terminology is expected to increase.

Citations

Citations to this article as recorded by

Characteristics and Distribution of Surgical Diseases in North Korean Research Papers Published between 2006 and 2017
Yo Han Lee, Namkee Oh, Hyerim Kim, Shin Ha
Journal of Korean Medical Science.2021;[Epub] CrossRef
Assessing the pharmacy students’ knowledge of common medical terms after a curricular change in Saudi Arabia
Yazed AlRuthia, Monira Alwhaibi, Haya Almalag, Hadeel Alkofide, Bander Balkhi, Amani Almejel, Fahad Alshammari, Fawaz Alharbi, Ibrahim Sales, Yousif Asiri
Saudi Pharmaceutical Journal.2020; 28(6): 763. CrossRef

Patient-Controlled Nutrition After Abdominal Surgery: Novel Concept Contrary to Surgical Dogma: Hyung Ook Kim, Mingoo Kang, Sung Ryol Lee, Kyung Uk Jung, Hungdai Kim, Ho-Kyung Chun; Ann Coloproctol. 2018;34(5):253-258. Published online October 31, 2018; DOI: https://doi.org/10.3393/ac.2018.05.29

4,699 View
134 Download
1 Web of Science
3 Citations

Abstract PDF

Purpose
According to surgical dogma, patients who are recovering from general anesthesia after abdominal surgery should begin with a clear liquid diet, progress to a full liquid diet and then to a soft diet before taking regular meals. We propose patient-controlled nutrition (PCN), which is a novel concept in postoperative nutrition after abdominal surgery.
Methods
A retrospective pilot study was conducted to evaluate the feasibility and effects of PCN. This study was carried out with a total of 179 consecutive patients who underwent a laparoscopic appendectomy between August 2014 and July 2016. In the PCN group, diet was advanced depending on the choice of the patients themselves; in the traditional group, diet was progressively advanced to a full liquid or soft diet and then a regular diet as tolerated. The primary endpoints were time to tolerance of regular diet and postoperative hospital stay.
Results
Time to tolerance of a regular diet (P < 0.001) and postoperative hospital stay (P < 0.001) showed statistically significant differences between the groups. Multivariate analysis using linear regression showed that the traditional nutrition pattern was the only factor associated with postoperative hospital stay (P < 0.001). Multivariate analysis using logistic regression showed that traditional nutrition was the only risk factor associated with prolonged postoperative hospital stay (≥3 days).
Conclusion
After abdominal surgery, PCN may be a feasible and effective concept in postoperative nutrition. In our Early Recovery after Surgery program, our PCN concept may reduce the time to tolerance of a regular diet and shorten the postoperative hospital stay.

Citations

Citations to this article as recorded by

Bilateral Exchange: Enteral Nutrition Clinical Decision Making in Pediatric Surgery Patients
Manisha B. Bhatia, Cassandra M. Anderson, Abdiwahab N. Hussein, Brian Opondo, Nereah Aruwa, Otieno Okumu, Sarah G. Fisher, Tasha Sparks Joplin, JoAnna L. Hunter-Squires, Brian W. Gray, Peter W. Saula
Journal of Surgical Research.2024; 295: 139. CrossRef
Clinical pharmacist intervention in Appendectomy - Dexmedetomidine as an adjunct therapy ‎
Bushra Abdel-Hadi, Sami Raid Abdel-Fattah
Journal Of Advanced Pharmacy Education And Research.2022; 12(2): 1. CrossRef
外科患者の栄養管理における給食の意義

The Japanese Journal of SURGICAL METABOLISM and NUTRITION.2021; 55(2): 57. CrossRef

Clinical Outcomes of a Redo for a Failed Colorectal or Coloanal Anastomosis: In Teak Woo, Jun Seok Park, Gyu-Seog Choi, Soo Yeun Park, Hye Jin Kim, In Kyu Park; Ann Coloproctol. 2018;34(5):259-265. Published online October 31, 2018; DOI: https://doi.org/10.3393/ac.2018.05.04

4,567 View
131 Download
12 Web of Science
13 Citations

Abstract PDF

Purpose
Redo surgery in patients with a persistent anastomotic failure (PAF) is a rare procedure, and data about this procedure are lacking. This study aimed to evaluate the surgical outcomes of redo surgery in such patients.
Methods
Patients who underwent a redo anastomosis for PAF from January 2004 to November 2016 were retrospectively evaluated. Data from a prospective colorectal database were analyzed. Success was defined as the combined absence of any anastomosis-related complications and a stoma at the last follow-up.
Results
A total of 1,964 patients who underwent curative surgery for rectal cancer during this study period were included. Among them, 32 consecutive patients underwent a redo anastomosis for PAF. Thirteen patients of those 32 had major anastomotic dehiscence with a pelvic sinus, 12 had a recto-vaginal fistula, and 7 had anastomosis stenosis. There were no postoperative deaths. The median operation time was 255 minutes (range, 80–480 minutes), and the median blood loss was 80 mL (range, 30–1,000 mL). The overall success rate was 78.1%, and the morbidity rate was 40.6%. Multivariable analyses showed that the primary tumor height at the lower level was the only statistically significant risk factor for redo surgery (P = 0.042; hazard ratio, 2.444).
Conclusion
In our experience, a redo anastomosis is a feasible surgical option that allows closure of a stoma in nearly 80% of patients. Lower tumor height (<5 cm from the anal verge) is the only independent risk factor for nonclosure of defunctioning stomas after primary rectal surgery.

Citations

Citations to this article as recorded by

Long-term Complications of Laparoscopic or Robotic Lateral Pelvic Node Dissection After Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer
Hye Jin Kim, Gyu-Seog Choi, Jun Seok Park, Soo Yeun Park, Seung Ho Song, Sung Min Lee, Min Hye Jeong, Seung Hyun Cho
Diseases of the Colon & Rectum.2024; 67(4): 505. CrossRef
Outcomes of redo for failed colorectal or coloanal anastomoses: a systematic review and meta-analysis
Ricardo Purchio Galletti, Gabriel Andrade Agareno, Lucas de Abreu Sesconetto, Rafael Benjamim Rosa da Silva, Rafael Vaz Pandini, Lucas Soares Gerbasi, Victor Edmond Seid, Sérgio Eduardo Alonso Araujo, Francisco Tustumi
Annals of Coloproctology.2023; 39(5): 375. CrossRef
Turnbull-Cutait Pull-Through Procedure Is an Alternative to Permanent Ostomy in Patients With Complex Pelvic Fistulas
Olga A. Lavryk, Carla F. Justiniano, Bethany Bandi, Crinuta Floruta, Scott R. Steele, Tracy L. Hull
Diseases of the Colon & Rectum.2023; 66(12): 1539. CrossRef
Dealing with Complications of Colorectal Surgery Using the Transanal Approach—When and How?
K. Talboom, P. J. Tanis, W. A. Bemelman, R. Hompes
Clinics in Colon and Rectal Surgery.2022; 35(02): 155. CrossRef
Multimodal treatment of colorectal postsurgical leaks: long-term results of the over-the-scope clip (OTSC) application
Damiano CHIARI, Carlotta LA RAJA, Benedetto MANGIAVILLANO, Paolo VERONESI, Marco PLATTO, Walter ZULIANI
Minerva Surgery.2022;[Epub] CrossRef
Re-do laparoscopic esophagojejunostomy for anastomotic stenosis after laparoscopic total gastrectomy in gastric cancer
Dai Manaka, Sayuri Konishi, Hideo An, Kiyotaka Kawaguchi, Machi Yoneda, Masashi Fushitani, Takano Ota, Michina Morioka, Yusuke Okamura, Atsushi Ikeda, Naoya Sasaki, Shinya Hamasu, Ryuta Nishitai
Langenbeck's Archives of Surgery.2022; 407(7): 3133. CrossRef
Redo-laparoscopy in the management of complications after laparoscopic colorectal surgery: a systematic review and meta-analysis of surgical outcomes
P. Fransvea, G. Costa, L. D’Agostino, G. Sganga, A. Serao
Techniques in Coloproctology.2021; 25(4): 371. CrossRef
Transanal Minimally Invasive Surgery: An Effective Approach for Patients Who Require Redo Pelvic Surgery for Anastomotic Failure
Susanna S. Hill, Cristina R. Harnsberger, Sue J. Hahn, Paul R. Sturrock, Jennifer S. Davids, Karim Alavi, Justin A. Maykel
Diseases of the Colon & Rectum.2021; 64(3): 349. CrossRef
Re-Operative Laparoscopic Colorectal Surgery: A Systematic Review
Constantine Halkias, Athanasios Zoikas, Zoe Garoufalia, Michalis K. Konstantinidis, Argyrios Ioannidis, Steven Wexner
Journal of Clinical Medicine.2021; 10(7): 1447. CrossRef
Second redo surgery after two consecutive failures of a colorectal or coloanal anastomosis: is it reasonable?
Camélia Labiad, Marie Monsinjon, Massimo Giacca, Yves Panis
International Journal of Colorectal Disease.2021; 36(9): 2057. CrossRef
Treatment Modalities for Anastomotic Leakage in Rectal Cancer Surgery
Deborah S. Keller, K. Talboom, C.P.M van Helsdingen, Roel Hompes
Clinics in Colon and Rectal Surgery.2021; 34(06): 431. CrossRef
Optimal strategies of rectovaginal fistula after rectal cancer surgery
In Teak Woo, Jun Seok Park, Gyu-Seog Choi, Soo Yeun Park, Hye Jin Kim, Hee Jae Lee
Annals of Surgical Treatment and Research.2019; 97(3): 142. CrossRef
Safety of coloanal/ileoanal anastomosis during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: results of 20 consecutive patients
Ozgul Duzgun, Murat Kalin
Journal of International Medical Research.2019; 47(10): 4911. CrossRef

Postoperative Outcomes of Stoma Takedown: Results of Long-term Follow-up: Bomina Paik, Chang Woo Kim, Sun Jin Park, Kil Yeon Lee, Suk-Hwan Lee; Ann Coloproctol. 2018;34(5):266-270. Published online October 10, 2018; DOI: https://doi.org/10.3393/ac.2017.12.13

4,710 View
158 Download
6 Web of Science
7 Citations

Abstract PDF

Purpose
Stoma takedown is a frequently performed procedure with considerable postoperative morbidities. Various skin closure techniques have been introduced to reduce surgical site infections. The aim of this study was to assess postoperative outcomes after stoma takedown during a long-term follow-up period.
Methods
Between October 2006 and December 2015, 84 consecutive patients underwent a colostomy or ileostomy takedown at our institution. Baseline characteristics and perioperative outcomes were analyzed through retrospective reviews of medical records.
Results
The proportion of male patients was 60.7%, and the mean age of the patients was 59.0 years. The overall complication rate was 28.6%, with the most common complication being prolonged ileus, followed by incisional hernia, anastomotic leakage, surgical site infection, anastomotic stenosis, and entero-cutaneous fistula. The mean follow-up period was 64.3 months. The univariate analysis revealed no risk factors related to overall complications or prolonged ileus.
Conclusion
The postoperative clinical course and long-term outcomes following stoma takedown were acceptable. Stoma takedown is a procedure that can be performed safely.

Citations

Citations to this article as recorded by

Comparing Surgical Site Infection Rate Between Primary Closure and Rhomboid Flap After Stoma Reversal
Che-Ming Chu, Chih-Cheng Chen, Yu-Yao Chang, Kai-Jyun Syu, Shih-Lung Lin
Annals of Plastic Surgery.2024; 92(1S): S33. CrossRef
TIMING OF THE STOMA REVERSAL, WHAT IS THE SAFE PERIOD?: A RETROSPECTIVE OBSERVATIONAL STUDY
GIRIDHAR ASHWATH, ESHWAR KATHIRESAN MANASIJAN, ANTHONY P ROZARIO
Asian Journal of Pharmaceutical and Clinical Research.2024; : 181. CrossRef
Diverting ileostomy in benign colorectal surgery: the real clinical cost analysis
F. Ascari, G. Barugola, G. Ruffo
Updates in Surgery.2024;[Epub] CrossRef
Laparoscopic versus open Hartmann reversal: a propensity score matching analysis
Li Tan, Xiao-Yu Liu, Bin Zhang, Lian-Lian Wang, Zheng-Qiang Wei, Dong Peng
International Journal of Colorectal Disease.2023;[Epub] CrossRef
Defunctioning stoma in anterior resection for rectal cancer does not impact anastomotic leakage: a national population-based cohort study
Eihab Munshi, Marie-Louise Lydrup, Pamela Buchwald
BMC Surgery.2023;[Epub] CrossRef
Surgical Site Infection After Stoma Reversal: A Comparison Between Linear and Purse-String Closure
Muhammad Awais Khan, Khurram Niaz, Shahzeb Asghar, Maaz A Yusufi, Mohtamam Nazir, Syed Muhammad Ali, Aryan Ahmed, Akeel Ahamed Salahudeen, Talha Kareem
Cureus.2023;[Epub] CrossRef
Factors Predicting the Reversal of Hartmann’s Procedure
Ömer Yalkın, Fatih Altıntoprak, Mustafa Yener Uzunoğlu, Yasin Alper Yıldız, Muhammet Burak Kamburoğlu, Necattin Fırat, Fehmi Çelebi, Mihajlo Jakovljevic
BioMed Research International.2022; 2022: 1. CrossRef

Case Report

Abdominosacral Resection in the Management of Large-Size Retrorectal Tumors: A Report of 2 Rare Cases: Yuda Handaya, Sutamto Wibowo; Ann Coloproctol. 2018;34(5):271-276. Published online October 10, 2018; DOI: https://doi.org/10.3393/ac.2017.12.01

6,181 View
130 Download

Abstract PDF: Management of large-size retrorectal gastrointestinal stromal tumors (GISTs) is complex and challenging from diagnosis to treatment. This may create technical difficulties in surgical access and complete resection of the tumor. The abdominosacral resection has the benefit of improved visualization via the anterior incision, with enhanced exposure of the midrectal area, which makes resecting the tumor completely via the posterior approach easier. We report 2 cases of patients with a retrorectal GIST and neurofibromatosis type 1, one in a 27-year-old woman with a defecation complaint and the other in a 58-year-old woman with a defecation and urination complaint. Based on the anatomical pathology, both patients were diagnosed with a GIST. The tumors were excised via an abdominosacral resection. Retrorectal GISTs are rare, and abdominosacral resection allows complete resection of a large-size retrorectal GIST with low morbidity and an absence of functional impairment. The abdominosacral resection should be considered in certain situations.

First
Prev
Page of 1
Next
Last

Previous issues